Assessment of Drug Liking In Peri-procedural Clinical Settings

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions

Drug Liking

Interventions

DRUG

Droperidol

Medication administered as a single intravenous dose.

DRUG

Placebo

Matching Placebo given by single intravenous (IV) administration.

Trial Locations (1)

Stanford Hospital, Palo Alto

All Listed Sponsors

lead

Stanford University

OTHER